Litcius/Paper detail

Selenium-Containing Carrier-Free Assemblies with Aggregation-Induced Emission Property Combine Cancer Radiotherapy with Chemotherapy

Tianyu Li, Shuojiong Pan, Hao Zhuang, Shiqian Gao, Huaping Xu

2020ACS Applied Bio Materials53 citationsDOI

Abstract

Developing multifunctional carrier-free nanomedicine with high efficacy attracts tremendous attention in cancer treatment. Here, we develop selenium-containing carrier-free assemblies with aggregation-induced emission (AIE) property, which achieve the combination of cancer radiotherapy with chemotherapy. Under γ-radiation, diselenide bonds in the assemblies can be cleaved to form seleninic acid, which exhibits anticancer activity by upregulating the reactive oxygen species (ROS) levels in cancer cells. The incorporation of AIE groups further endows the selenium-containing assemblies with the ability of bioimaging. Their self-assembly behavior change under γ-radiation can be consequently observed in situ. The system combines cancer radiotherapy with chemotherapy, which exhibits improved anticancer activity.

Topics & Concepts

NanomedicineRadiation therapyDiselenideReactive oxygen speciesCancer cellSeleniumChemotherapyMaterials scienceCancerNanotechnologyCancer therapyCancer researchChemistryBiophysicsNanoparticleMedicineBiochemistryOrganic chemistryInternal medicineBiologyLuminescence and Fluorescent MaterialsNanoplatforms for cancer theranosticsCarbon and Quantum Dots Applications
Selenium-Containing Carrier-Free Assemblies with Aggregation-Induced Emission Property Combine Cancer Radiotherapy with Chemotherapy | Litcius